A group of recovered COVID -19 patients of Tablighi Jamat who attended the religious congregation of Nizammudin, Delhi has decided to donate their plasma for plasma therapy clinical trial in the Tamil Nadu state.
Local religious leaders are also encouraging recovered patients to donate their plasma when the government makes an announcement regarding trying to find out the cure of virus through the therapy.
Some people said that apart from helping in treating someone we want to counter the baseless allegation hurdled against us ever since the media threw all the blame on the jamati for spreading the virus in the country where they didn’t even mention about other religious congregations happened at different states.
“As soon as I got discharged, I met the district administration officials and the dean of the hospital and told them that they may contact me anytime if they needed me to donate my plasma” shared by thirty-eight-year old businessmen Mohammad Abbas from Tiruppur was discharged from the ESI hospital in Coimbatore on Sunday.
A group of recovered patients from Theni released a video where they expressed their willingness to donate their plasma, while the secretary of Erode District Masjid Coordinator committee told DH that multiple patients are willing to provide their support in containing the COVID-19.
The state government of Tamil Nadu asked for permission from the Indian Council for Medical Research for conducting plasma therapy and ICMR gave the green signal for this. Health Minister C Vijayabhaskar informed that two of the hospital of Tamil Nadu has been equipped to carry out the clinical trials which are Rajiv Gandhi Government General Hospital and Dr. MGR Medical University.
Sulthan from Chennai, an electrical engineer at a private firm has voluntarily coordinated with the Delhi returnees from across the state for this initiative though he himself was not amongst those who attended the Nizzamudin congregation.
Plasma therapy for COVID-19 works as Plasma from a recovered patient of the same virus, transfused into a coronavirus patient who will be in critical condition. The idea behind the therapy is that immunity can be transferred from a healthy person to a sick person using convalescent plasma. The therapy uses antibodies from the blood of a recovered coronavirus patient to treat another critical patient. The recovered COVID-19 patient’s blood develops antibodies to battle against COVID-19. Once the blood of the first patient is infused to the second patient, those antibodies will start fighting against coronavirus in the second person